Investigation of Hypoxia-Inducible Factor 1-Alpha Levels and Its Change with High Flow Oxygen Therapy in COVID-19 Patients
Genel Tıp Dergisi · 02.07.2026 · 36 (2026) · 1-6
DOI: 10.54005/geneltip.1452831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genel Tıp Dergisi, online erschienen am 02.07.2026. Verfasst von Çiğdem Damla Deniz und 8 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
Aim
In this study, we aimed to examine the change in Hypoxia-inducible factor 1-alpha (HIF-1α) levels and to determine the prognostic value of HIF-1α in COVID-19 patients receiving high-flow oxygen therapy.Materials and Methods: Our study was conducted on 30 patients who were followed up in the intensive care unit and 30 healthy volunteers. Enzyme-Linked Immunosorbent Assay method was used to measure HIF-1α concentrations. Correlations of HIF-1α levels with clinical, biochemical and radiographic data were analyzed.
Results
When the HIF-1α levels of discharged and non-survivors COVID-19 patients were compared, it was found to be significantly higher in non-surviving patients (p = 0.016). Serum levels of HIF-1α in the COVID-19 group were significantly higher than in the control group (p<0.001). When the presence of subpleural and fibrotic bands on chest X-ray and HIF-1α levels were compared, a significant difference was found (p<0.001). Ac-cording to the Receiver Operating Characteristic (ROC) analysis results, the cut-off value for HIF-1α was 0.41, the sensitivity was 87%, the specificity was 89%, and the area under the ROC curve value was 0.95.
Conclusion
We found that COVID-19 patients with severe disease have a significantly higher serum HIF-1α concentration. HIF-1α may be a potential therapeutic target for virus-induced inflammatory diseases and COVID-19.
Zitieren
APA
Deniz, Ç. D., Yücel, F., Şenay, H., Kacar, F., İyisoy, M. S., Baran, N., Kozanhan, B., Eryılmaz, M. A., & Koç, M. (2026). Investigation of Hypoxia-Inducible Factor 1-Alpha Levels and Its Change with High Flow Oxygen Therapy in COVID-19 Patients. Genel Tıp Dergisi, 36(2026), 1-6. https://doi.org/10.54005/geneltip.1452831
Vancouver
Deniz ÇD, Yücel F, Şenay H, Kacar F, İyisoy MS, Baran N, et al. Investigation of Hypoxia-Inducible Factor 1-Alpha Levels and Its Change with High Flow Oxygen Therapy in COVID-19 Patients. Genel Tıp Dergisi. 2026;36(2026):1-6. doi:10.54005/geneltip.1452831
BibTeX
@article{Deniz2026,
author = {Deniz, Çiğdem Damla and Yücel, Fatih and Şenay, Hasan and Kacar, Fatma and İyisoy, Mehmet Sinan and Baran, Nahide and Kozanhan, Betül and Eryılmaz, Mehmet Ali and Koç, Mehmet},
title = {Investigation of Hypoxia-Inducible Factor 1-Alpha Levels and Its Change with High Flow Oxygen Therapy in COVID-19 Patients},
journal = {Genel Tıp Dergisi},
year = {2026},
volume = {36},
number = {2026},
pages = {1--6},
doi = {10.54005/geneltip.1452831}
}
EUVIMED